MULLIGANS BAR LIVERPOOL LTD

Company number 13971517 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

MULLIGANS BAR LIVERPOOL LTD - Analysis Report

Company Number: 13971517

Analysis Date: 2025-07-29 18:47 UTC

Financial Health Assessment for MULLIGANS BAR LIVERPOOL LTD (as at 31 March 2024)


1. Financial Health Score: D

Explanation:
The company shows signs of financial distress with a very thin positive net asset base and deteriorating working capital position compared to the previous year. While it remains active and solvent on paper, the sharp drop in net assets from £117k positive to just £2k, combined with negative net current assets, indicates a fragile financial condition requiring urgent attention.


2. Key Vital Signs:

Metric 2024 (£) 2023 (£) Interpretation
Fixed Assets 194,944 197,450 Stable investment in tangible assets (fixtures & fittings). No significant disposals.
Current Assets 115,780 88,942 Increased current assets driven by higher cash and stock levels—a positive sign.
Cash at Bank 19,922 1,755 Improved cash position suggests better liquidity management but still low relative to liabilities.
Debtors 72,058 78,787 Slight reduction in receivables; indicates consistent or improved collections.
Current Liabilities 221,114 263,243 Decreased but still high short-term obligations, creating pressure on working capital.
Net Current Assets -105,334 -174,301 Negative working capital (current assets < current liabilities) - a symptom of liquidity stress.
Long-Term Liabilities 87,299 140,457 Bank loans reduced, which is positive but still substantial debt burden.
Net Assets (Equity) 2,311 117,308 Dramatic fall in shareholder funds; borderline net equity raises concerns about solvency.
Profit and Loss Reserve 2,212 -117,407 Shift from accumulated losses to a small positive reserve; could indicate recent profit or capital injection.
Number of Employees 27 9 Tripling of staff size suggests expansion but also higher fixed costs.

3. Diagnosis:

The company’s financial "vitals" reveal a mixed but concerning picture:

  • Liquidity Symptoms: Despite a rise in cash and stock, current liabilities remain significantly higher than current assets, resulting in negative net current assets (working capital). This is akin to a patient with a weak pulse—there is some life but struggling to sustain immediate obligations.

  • Solvency Concerns: The near-zero net assets after years of positive equity indicate diminishing financial reserves. It suggests the company may be living close to its means, with limited buffer to absorb unexpected shocks. This fragile equity is a "symptom of distress" hinting at potential solvency risks if adverse conditions persist.

  • Debt Burden: Although long-term debt has decreased, £87k remains, which is sizeable for a company of this size. Coupled with negative working capital, the debt servicing could strain cash flows.

  • Operational Expansion: The increase in employees from 9 to 27 shows growth ambitions but also raises fixed cost commitments, which may be pressurizing cash flow if revenue growth isn’t proportional.

  • Asset Management: Tangible assets remain stable, but increased stock levels and receivables suggest more capital tied up in operations, possibly affecting liquidity.

Overall, the financial health indicates a business under stress but not yet in critical failure. It's like a patient who has recovered slightly from a severe illness but remains weak and vulnerable to relapse.


4. Recommendations:

To improve financial wellness and stabilize the business, I advise the following actions:

  1. Improve Working Capital Management:

    • Tighten credit control to reduce debtor days.
    • Review stock management to avoid overstocking and free up cash.
    • Negotiate longer payment terms with suppliers to ease current liabilities pressure.
  2. Strengthen Liquidity:

    • Build and maintain a healthy cash buffer through better cash flow forecasting and management.
    • Consider short-term financing options only if they improve liquidity without increasing risk.
  3. Cost Control:

    • Review staffing and overheads relative to revenue to ensure fixed costs do not outpace cash generation.
    • Explore operational efficiencies in procurement and service delivery.
  4. Debt Restructuring:

    • Engage with lenders to potentially restructure bank loans to reduce immediate repayment pressure.
    • Explore equity injection options with shareholders or external investors to bolster net assets.
  5. Financial Monitoring:

    • Establish regular financial health checks focusing on liquidity ratios and cash flow to detect early warning signs.
    • Prepare detailed budgets and forecasts aligned with operational realities.
  6. Strategic Review:

    • Assess market positioning and growth strategy to ensure expansion is sustainable and profitable.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.